title: Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.
abstract: How parathyroid hormone (PTH) increases bone mass is unclear, but understanding this phenomenon is significant to the improvement of osteoporosis therapy. Nmp4/CIZ is a nucleocytoplasmic shuttling transcriptional repressor that suppresses PTH-induced osteoblast gene expression and hormone-stimulated gains in murine femoral trabecular bone. To further characterize Nmp4/CIZ suppression of hormone-mediated bone growth, we treated 10-week-old Nmp4-knockout (KO) and wild-type (WT) mice with intermittent human PTH(1-34) at 30 μg/kg daily or vehicle, 7 days/week, for 2, 3, or 7 weeks. Null mice treated with hormone (7 weeks) gained more vertebral and tibial cancellous bone than WT animals, paralleling the exaggerated response in the femur. Interestingly, Nmp4/CIZ suppression of this hormone-stimulated bone formation was not apparent during the first 2 weeks of treatment. Consistent with the null mice enhanced PTH-stimulated addition of trabecular bone, these animals exhibited an augmented hormone-induced increase in serum osteocalcin 3 weeks into treatment. Unexpectedly, the Nmp4-KO mice displayed an osteoclast phenotype. Serum C-terminal telopeptide, a marker for bone resorption, was elevated in the null mice, irrespective of treatment. Nmp4-KO bone marrow cultures produced more osteoclasts, which exhibited elevated resorbing activity, compared to WT cultures. The expression of several genes critical to the development of both osteoblasts and osteoclasts was elevated in Nmp4-KO mice at 2 weeks, but not 3 weeks, of hormone exposure. We propose that Nmp4/CIZ dampens PTH-induced improvement of trabecular bone throughout the skeleton by transiently suppressing hormone-stimulated increases in the expression of proteins key to the required enhanced activity and number of both osteoblasts and osteoclasts.
authors: Department of Anatomy and Cell Biology, Indiana University School of Medicine (IUSM), Medical Science Bldg., Indianapolis, IN 46202, USA.
authors: Paul
authors: P
authors: Childress
authors: Binu K
authors: BK
authors: Philip
authors: Alexander G
authors: AG
authors: Robling
authors: Angela
authors: A
authors: Bruzzaniti
authors: Melissa A
authors: MA
authors: Kacena
authors: Nicoletta
authors: N
authors: Bivi
authors: Lilian I
authors: LI
authors: Plotkin
authors: Aaron
authors: A
authors: Heller
authors: Joseph P
authors: JP
authors: Bidwell
references: Nature. 2003 May 15;423(6937):337-42
references: 12748652
references: Nature. 1996 Oct 10;383(6600):528-31
references: 8849724
references: J Bone Miner Res. 2009 Sep;24(9):1586-97
references: 19419301
references: J Biol Chem. 2002 Jan 4;277(1):816-22
references: 11641401
references: J Exp Med. 2005 Mar 21;201(6):961-70
references: 15781586
references: J Cell Sci. 2006 Oct 15;119(Pt 20):4187-98
references: 16984976
references: J Biol Chem. 2005 Jan 28;280(4):3104-11
references: 15513917
references: Endocrinology. 2005 Nov;146(11):4584-96
references: 16081645
references: Arch Intern Med. 2006 Jun 12;166(11):1209-17
references: 16772249
references: Bone. 2010 Feb;46(2):259-66
references: 19766748
references: J Biol Chem. 2007 Nov 9;282(45):33098-106
references: 17690108
references: Bone. 2002 Jul;31(1):126-35
references: 12110425
references: Ann Rheum Dis. 2010 Jan;69 Suppl 1:i86-88
references: 19995753
references: Calcif Tissue Int. 1999 Nov;65(5):369-73
references: 10541762
references: J Cell Physiol. 2009 Jun;219(3):734-43
references: 19189321
references: Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E289-96
references: 15026307
references: Cell Metab. 2006 Aug;4(2):111-21
references: 16890539
references: BMC Mol Biol. 2005 Feb 18;6:4
references: 15720708
references: Nature. 2008 Jul 10;454(7201):221-5
references: 18548006
references: PLoS One. 2008 Aug 13;3(8):e2942
references: 18698360
references: Development. 2004 Nov;131(22):5717-25
references: 15509771
references: J Bone Miner Res. 2001 Jan;16(1):10-23
references: 11149472
references: Am J Health Syst Pharm. 2008 Mar 15;65(6):532-9
references: 18319498
references: Nature. 2002 Apr 18;416(6882):744-9
references: 11961557
references: Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E714-25
references: 20028966
references: J Bone Miner Res. 1987 Dec;2(6):595-610
references: 3455637
references: J Biol Chem. 2002 Dec 13;277(50):48868-75
references: 12364326
references: Immunol Rev. 2009 Sep;231(1):241-56
references: 19754901
references: J Bone Miner Res. 1997 Feb;12(2):172-8
references: 9041048
references: J Bone Miner Res. 2002 May;17(5):808-16
references: 12009011
references: J Biol Chem. 2003 Dec 12;278(50):50259-72
references: 14523023
references: Ann N Y Acad Sci. 2007 Nov;1116:227-37
references: 18083930
references: Bone. 2006 Nov;39(5):1018-1025
references: 16765661
references: BMC Dev Biol. 2005 Dec 03;5:27
references: 16324220
references: Trends Endocrinol Metab. 2004 Mar;15(2):60-5
references: 15036251
references: J Exp Med. 2005 Mar 21;201(6):841-3
references: 15781576
references: Endocrinology. 2006 May;147(5):2583-90
references: 16484320